From November 8, 2022 to December 31, 2022, the company has repurchased 4,427,600 shares, representing 1.14% for Ã4,900.29 million. With this, the company has completed the repurchase of 4,427,600 shares, representing 1.14% for Ã4,900.29 million under the buyback announced on November 8, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,836 JPY | +1.60% |
|
+2.46% | +30.68% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.68% | 3.98B | |
+55.35% | 848B | |
+31.64% | 627B | |
-0.10% | 363B | |
+15.47% | 318B | |
+13.10% | 299B | |
+15.51% | 243B | |
+16.72% | 225B | |
+16.54% | 179B | |
+4.31% | 167B |
- Stock Market
- Equities
- 4536 Stock
- News Santen Pharmaceutical Co., Ltd.
- Tranche Update on Santen Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 8, 2022.